1. Home
  2. GDTC vs PXS Comparison

GDTC vs PXS Comparison

Compare GDTC & PXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • PXS
  • Stock Information
  • Founded
  • GDTC 2018
  • PXS 2015
  • Country
  • GDTC Singapore
  • PXS Greece
  • Employees
  • GDTC N/A
  • PXS N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • PXS Marine Transportation
  • Sector
  • GDTC Health Care
  • PXS Consumer Discretionary
  • Exchange
  • GDTC Nasdaq
  • PXS Nasdaq
  • Market Cap
  • GDTC 28.0M
  • PXS 29.7M
  • IPO Year
  • GDTC 2023
  • PXS N/A
  • Fundamental
  • Price
  • GDTC $1.86
  • PXS $3.03
  • Analyst Decision
  • GDTC Buy
  • PXS
  • Analyst Count
  • GDTC 1
  • PXS 0
  • Target Price
  • GDTC $5.00
  • PXS N/A
  • AVG Volume (30 Days)
  • GDTC 10.3K
  • PXS 22.5K
  • Earning Date
  • GDTC 01-01-0001
  • PXS 08-11-2025
  • Dividend Yield
  • GDTC N/A
  • PXS N/A
  • EPS Growth
  • GDTC N/A
  • PXS N/A
  • EPS
  • GDTC N/A
  • PXS 0.63
  • Revenue
  • GDTC $368,838.00
  • PXS $49,342,000.00
  • Revenue This Year
  • GDTC $5.37
  • PXS N/A
  • Revenue Next Year
  • GDTC N/A
  • PXS $31.36
  • P/E Ratio
  • GDTC N/A
  • PXS $4.54
  • Revenue Growth
  • GDTC N/A
  • PXS 8.07
  • 52 Week Low
  • GDTC $1.20
  • PXS $2.53
  • 52 Week High
  • GDTC $4.05
  • PXS $5.53
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 41.07
  • PXS 47.14
  • Support Level
  • GDTC $1.96
  • PXS $2.83
  • Resistance Level
  • GDTC $2.26
  • PXS $2.99
  • Average True Range (ATR)
  • GDTC 0.10
  • PXS 0.08
  • MACD
  • GDTC -0.02
  • PXS 0.00
  • Stochastic Oscillator
  • GDTC 17.95
  • PXS 45.42

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About PXS Pyxis Tankers Inc.

Pyxis Tankers Inc is an international maritime transportation company focused on mid-sized eco-vessels for the product tanker and dry-bulk sectors. It owns a fleet that comprises double-hull product tankers employed under a mix of short- and medium-term time charters and spot charters. The fleet owned by the company includes Konkar Ormi, Pyxis Lamda, Konkar Venture, Pyxis Karteria, and others. Each of the vessels in the fleet is capable of transporting refined petroleum products, such as naphtha, gasoline, jet fuel, kerosene, diesel, fuel oil, and other liquid bulk items, such as vegetable oils and organic chemicals. The company operates under two reportable segments, Tanker Vessels, which derive maximum revenue, and Dry-bulk Vessels.

Share on Social Networks: